|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| The effect of hormonal contraception on genital tract shedding of HIV-1. |
| Wang CC; McClelland RS; Overbaugh J; Reilly M; Panteleeff DD |
| AIDS. 2004 Jan 23;18(2):205-209. |
| A previous cross-sectional study reported that hormonal contraception may be associated with increased infectivity |
| in HIV-1 infected women. We conducted a prospective study to determine if cervical shedding of HIV-1 increased |
| after initiating hormonal contraception. Shedding of HIV-1 DNA (a marker of HIV-1 infected cells) and HIV-1 RNA |
| were measured before and after initiating hormonal contraception. HIV-1 seropositive women were recruited from a |
| Kenyan family planning clinic. At baseline, cervical secretions were collected for HIV-1 DNA and RNA assays in |
| women initiating hormonal contraception; follow-up samples were collected a median of 64 days later. One-hundred |
| and one women chose depot medroxyprogesterone (Depo), 53 chose low-dose oral contraceptives (OC), seven high- |
| dose OC, and 52 progesteroneonly OC. At follow-up, there was a significant increase in the prevalence of cervical |
| HIV-1 DNA detection [from 42% to 52%, odds ratio (OR), 1.62; 95% confidence interval (CI), 1.03-2.63) for all |
| hormonal contraception combined, and a trend for an increase for each individual type. Although the prevalence of |
| cervical HIV-1 RNA increased slightly (from 82% to 86%; OR, 1.56; 95% CI, 0.83-3.03), the concentration of cervical |
| HIV-1 RNA did not change significantly overall (from 2.81 to 2.84 log10 copies/swab; P = 0.77) or for individual |
| contraception types. A modest but significant increase in shedding of HIV-1 DNA but not of HIV-1 RNA was detected |
| after starting hormonal contraception. Our results may have important implications regarding the infectivity of women |
| using hormonal contraception, and highlight the need for epidemiologic studies of transmission rates from women |
| using and not using hormonal contraception. (PubHealth.info Document ID: CONT1T 533-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "The effect of hormonal contraception on genital tract |
| shedding of HIV-1.", is(are) Wang CC; McClelland RS; Overbaugh J; Reilly M; Panteleeff DD. The source of this |
| article is "AIDS. 2004 Jan 23;18(2):205-209.". This article was published in 2004 in English language(s). |
| (PubHealth.info® Document ID: CONT1T 533-06. All rights reserved with PubHealth.info) PIN: 533 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |